IDOGEN — Idogen AB Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- SEK12.58m
- SEK9.60m
Annual income statement for Idogen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 27.9 | 32.8 | 26.2 | 39 | 48 |
| Operating Profit | -27.9 | -32.8 | -26.2 | -39 | -48 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.28 | -4.36 | -2.8 | -1.7 | -0.761 |
| Dividends per Share |